Open Nav
2018 Plenary Program

CRISPR and Gene Editing Tools to Advance Industrial Biotechnology

Tuesday, July 17, 2018
11:30 AM – 1:00 PM

Gene editing tools are revolutionizing the production of consumer products from food ingredients and intermediates, to packaging and household supplies.  Our dynamic panel will highlight the opportunities and challenges for the broad application of gene editing technology in industrial biosciences.  In addition, panelists will address appropriate communication and public engagement for these innovative technologies, and what it takes to gain public license to commercialize these products.  

Welcome Remarks: The Honorable James C. Greenwood, President and Chief Executive Officer, Biotechnology Innovation Organization 

Moderator: Roger Wyse, PhD, Managing Partner, Spruce Capital Partners


Doane Chilcoat, PhD, Director, Applied Science & Technology, Corteva Agriscience™, agriculture division of DowDuPont™

Stephan Herrera, Vice President, Strategy and Public Affairs, Evolva

J.J. Jones, Co-Founder, Roots & Legacies Consulting, Inc. 

Sylvia Rowe, President, SR Strategy, LLC


Biobased Materials Redesigning Consumer Markets and Fashion Trends

Wednesday, July 18, 2018
8:15 AM – 9:45 AM

Sponsored by: DuPont Biomaterials 

As consumers demand for sustainable apparel increases, biobased producers stand ready to deliver innovative, renewable solutions, while maintaining material performance.  Our expert panelists will discuss the perception of renewably sourced materials, new innovations in the space, and the opportunities and challenges to marketing and commercializing biobased consumer products.  

Moderator: Jim Lane, Editor and Publisher, The Digest 


Kimberly Falkenhayn, President, Okabashi Brands

Jens Klein, Managing Director and Chief Executive Officer, AMSilk

Christophe Schilling, PhD, President and Chief Executive Officer, Genomatica, Inc.


Industrial Biotech Thought Leaders: Winners of the George Washington Carver and Rosalind Franklin Awards

Wednesday, July 18, 2018
11:30 AM – 1:00 PM

Sponsored by: Intrexon Corporation 

As the World Congress celebrates 15 years of helping to grow and shape the industrial biotechnology sector, the industry continues to expand to new market segments and innovate in new ways. Our prestigious award winners and thought leaders will join Brent Erickson, Executive Vice President at BIO to discuss how industrial biotech has changed over the last 15 years, and highlight promising opportunities for growth in the future.

Moderator: Brent Erickson, Executive Vice President, Industrial and Environmental, Biotechnology Innovation Organization


Vonnie Estes, Consultant, Estes Consulting 

Patrick R. Guber, PhD, Chief Executive Officer, Gevo, Inc. 

Krysta Harden, Vice President, External Affairs and Chief Sustainability Officer, Corteva Agriscience™, agriculture divsion of DowDuPont™ 

Sang Yup Lee, PhD, Distinguished Professor and Dean, Korea Advanced Institute of Science and Technology 

>>Click here to learn more about BIO World Congress awards.


Industrial Biotechnology Innovation for Ag Feedstock Production Applications

Thursday, July 19, 2018
11:30 AM – 1:00 PM

Agriculture feeds the industrial biotechnology supply chain.  At the same time, industrial biotech companies are creating innovative microbial and biochemical products to enhance ag production.  From greater yield production to controlling pests and diseases, to changing the way a plant grows root systems, biotech companies are actively working to increase the health of the microbiome and to heal, fuel, and feed a growing global population.  Our expert panelists will discuss the innovative products currently employed in this space, as well as market trends in biorefinery feedstock production and future potential for this growing sector. 


Paul Zorner, PhD, President and Chief Executive Officer, Locus Agricultural Solutions


Richard Broglie, PhD, Chief Technology Offier, Pivot Bio

Matt McKnight, Chief Commercial Officer, Ginkgo Bioworks

Jenny Rooke, PhD, Founder, Managing Director, Genoa Ventures

Shawn Semones, PhD, Executive Vice President and Chief Technology Officer, Concentric